Acupuncture for CIPN in Breast Cancer Patients
The aim of this study is to collect preliminary data on the effectiveness of acupuncture for the treatment of CIPN in breast cancer patients.
Sensation Disorders|Neuropathy
DEVICE: Acupuncture
Changes in perceived neuropathy as measured by EORTC CIPN-20, This is a 20-item self-report multidimensional CIPN specific scale that measures sensory, motor and autonomic symptoms of a 1-4 Likert scale., At baseline, week 6 (treatment 12) and at week 10 (treatment 16)
Changes in perceived neuropathy as measured by Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT-GOG) Questionnaire, At baseline, week 6 (treatment 12) and at week 10 (treatment 16)|Changes in perceived neuropathy as measured by Visual Analogue Scale of Pain, At baseline, week 6 (treatment 12) and at week 10 (treatment 16)|Changes in quality of life as measured by EORTC QLQ-30, At baseline, week 6 (treatment 12) and at week 10 (treatment 16)
Ideally 10 patients experiencing peripheral neuropathy due to chemotherapy from breast cancer treatment will be included in this study.They will receive 16 total acupuncture treatments over 10 weeks including various points based off of research and classical text and scalp acupuncture.